Aims/hypothesis The aim of the study was to gain better insight into the mechanisms responsible for impaired glucose metabolism during late pregnancy. We explored the direct effects of progesterone on glucose metabolism of skeletal muscle. Methods Specimens of skeletal muscle from untreated rats were incubated with progesterone and rates of substrate fluxes through the various pathways of glucose metabolism were analysed. Results Progesterone dose-dependently reduced the rates of glucose and pyruvate oxidation (insulin-stimulated rates after 5 h of exposure to 1 and 10 μmol/l progesterone: glucose oxidation, −6±4%, NS, and −39±4%, p<0.001; pyruvate oxidation, −28±2% and −55±4%, p<0.001 each) and increased lactate release (+28±4% and +58±9%, p<0.005 each), which indicated inhibition of mitochondrial respiratory function. Impairment of cell respiration, e.g. by the specific inhibitor rotenone, is known to trigger a compensatory increase in glucose transport, but this response was blunted in the case of progesterone (change of glucose transport in response to 10 μmol/l progesterone vs 60 nmol/l rotenone, both causing a reduction in glucose oxidation by −39%: progesterone, +14±8% vs rotenone, +84±23%, p< 0.03). Further experiments dealt with the underlying mechanisms and revealed a rapid mode of action (50 μmol/l progesterone, reduction in insulin-stimulated glucose oxidation after 30 min: −29±7%, p<0.01) not affected by blockers of gene expression or the nuclear progesterone receptor. Conclusions/interpretation Progesterone inhibits cell respiration and at the same time suppresses a compensatory increase in glucose transport, causing cellular carbohydrate deficiency in isolated rat skeletal muscle. This effect is mediated by a direct, rapid and non-genomic mechanism and could contribute to pregnancy-associated changes in glucose homeostasis.
precise mechanisms and hormones responsible for these adaptations, which could serve to shift fuel substrate from maternal tissues to the fetus. While several peptide and steroid hormones could make a contribution, a strong line of evidence points at a predominant role of circulating progesterone, which during the course of pregnancy increases in tight association with the reduction in insulin-stimulated glucose disposal [3, 4] . The presumptive function of progesterone as a physiological modulator of glucose homeostasis is supported by parallel fluctuations of endogenous plasma progesterone concentrations and insulin sensitivity during the human menstrual cycle [5, 6] , as well as by a correlation between the plasma concentrations of progesterone and glucose in female mice studied randomly during their cycle [7] . Accordingly, insulin sensitivity is reduced in women taking progestins [8, 9] , while progesterone administration to rodents blunts the hypoglycaemic action of insulin and accelerates the obesity-associated deterioration of glucose homeostasis [7, 10] .
The precise mechanisms via which progesterone exerts its effects on glucose metabolism are not known, but skeletal muscle is predominantly responsible for reductions in insulin-stimulated glucose disposal associated with human pregnancy and with chronic progesterone and oestradiol treatment in dogs [11, 12] . Whereas effects of progesterone on pancreatic beta cells, hepatocytes and adipocytes [7, [13] [14] [15] are likely to influence glucose metabolism of skeletal muscle indirectly, the possible contribution of direct actions on muscle has received little attention. Based on promising results reported two decades ago [10, 16] , the present study set out to close this gap in knowledge. Using isolated tissue specimens, an approach that excludes indirect actions via other organs, the experiments aimed to thoroughly explore and analyse the effects of progesterone on glucose metabolism of rat skeletal muscle.
Methods

Rats
Sprague-Dawley rats (male, unless stated otherwise) were purchased from the breeding facilities of the Medical University of Vienna (Himberg, Austria). They were kept in an artificial 12 h light-dark cycle at constant room temperature and provided with conventional laboratory diet and tap water ad libitum. At an age of 5-7 weeks (approximately 150 g body weight) food, but not water, was withdrawn overnight and rats were killed by cervical dislocation between 09:00 and 10:00 hours. All experiments were performed according to local law and to the principles of good laboratory animal care.
Muscle incubation
Pretreatment period Immediately after killing, two longitudinal strips of soleus or extensor digitorum longus muscle per leg were prepared, weighed (approximately 25 mg per strip) and tied under tension on stainless steel clips [17] . Using procedures established at our laboratory [18] , muscles were immediately put into Erlenmeyer flasks coated with BlueSlick solution (Serva, Heidelberg, Germany) and provided with Cell Culture Medium 199 (pH 7.35, 5.5 mmol/l glucose; Sigma, St. Louis, MO, USA) containing supplements of 5 mmol/l HEPES, 25,000 U/l penicillin G, 25 mg/l streptomycin and 0.2 mg/l ciprofloxacine. Other additions depended on the specific experiment and included progesterone or other steroids (from Steraloids, Newport, RI, USA) dissolved in ethanol, and rotenone, RU-486, actinomycin D or cycloheximide (all from Sigma) dissolved in DMSO.
For the determination of fatty acid oxidation, the medium was additionally supplemented with 0.3% (w/v) fatty acid-free BSA and 300 μmol/l palmitate dissolved in ethanol. These additions were also used in experiments dealing with actinomycin D or cycloheximide, because their activities as inhibitors of transcription and protein synthesis, respectively, are documented under such conditions [18] . The final concentrations of DMSO and ethanol never exceeded 0.1 and 0.35% (v/v), respectively, and were always identical with those in the respective control. All incubations were under a continuous atmosphere of 95% O 2 -5% CO 2 . Prolonged pretreatment for 4 h, as applied in most experiments, was in flasks containing three muscle specimens and 15 ml medium. Shorter pretreatment was in flasks containing 3 ml medium and one muscle strip.
Measurement period After pretreatment, muscles were transferred into identical medium (one muscle strip in 3 ml medium per flask) additionally supplemented with trace amounts of d-[U- 14 
14 C]sucrose (all from Amersham Pharmacia Biotech UK, Little Chalfont, UK), and, if stated, with human insulin (Actrapid; Novo, Bagsvaerd, Denmark). Unless stated otherwise, the measurement period was 1 h, after which muscles were quickly removed from the flasks, blotted and frozen in liquid nitrogen.
Analyses
14 CO 2 produced from radiolabelled glucose, palmitate or pyruvic acid was trapped with a solution containing methanol and phenethylamine (1:1; referred to as glucose, palmitate or pyruvate oxidation) [19] . Rates of glucose and palmitate oxidation are given in mole per gram per hour as calculated from their specific activity in the incubation medium, whereas the oxidation rate of pyruvate, which was not present in the incubation medium, is given in counts per minute per gram per hour. For the measurement of glycogen storage, frozen muscle strips were lysed in 1 mol/l KOH at 70°C and the net rate of glucose incorporation into glycogen was calculated from the conversion of [ 14 C]glucose into [ 14 C]glycogen (referred to as glycogen synthesis) [19] . The glycogen content at the end of the experiment was determined by degrading glycogen in the muscle lysate to glucose with amyloglucosidase, followed by the measurement of glucose with an enzymatic kit (Human, Taunusstein, Germany). Rates of lactate release were calculated from lactate accumulated in the incubation medium as measured with a spectrophotometric lactate dehydrogenase method [20] . Intracellular accumulation of 2-deoxy-d-[ 3 H 2, 6 ]glucose was determined as described [19] and was corrected using d-[U- 14 C]sucrose as a marker for the extracellular space (referred to as glucose transport). The net rate of methionine incorporation into protein was calculated from the conversion of [
14 C]methionine into 14 C-labelled protein using muscle strips lysed in 1 mol/l NaOH (referred to as protein synthesis) [18] . For the determination of the cellular energy charge, muscle strips were extracted with 3 mol/l perchloric acid. ATP and phosphocreatine were measured spectrophotometrically after neutralisation with KOH [21] . mRNA encoding progesterone receptor membrane component 1
To examine the tissue-specific expression of Pgrmc1, the gene encoding progesterone receptor membrane component 1, tissue specimens were isolated immediately after killing and put into of RNAlater solution (Ambion, Austin, TX, USA; 1 ml/100 mg). Approximately 50 mg tissue were transferred into RNAzol B solution (Tel-Test, Friendswood, TX, USA) and homogenised for 1 min, before total RNA was isolated according to manufacturer's instructions. RNA content of the extract was determined photometrically (ratio 260:280 nm >1.9) and checked for quality by 1.5% agarose gel electrophoresis. One microgram of isolated RNA was treated with RNAse-free DNAse (Invitrogen, Carlsbad, CA, USA) and reverse transcribed into cDNA (Superscript II; Invitrogen) using poly T-A/-C/-G priming according to manufacturer's instruction. Expression of mRNA encoding for Rattus norvegicus progesterone receptor membrane component 1 was examined by PCR (forward primer: AGGTGTTCGACGTGACCAAAGG; reverse primer CACTCTTCCGAGCAGCCTCAC) and visualised by 1% agarose gel electrophoresis including a molecular weight marker (ΦX174 RF DNA/HaeIII fragments; Invitrogen). The predicted sequence of the detected transcript was analysed and confirmed by VBC-Genomics (Vienna, Austria). , lactate release (c) and net glycogen synthesis (d) were measured during the last hour. Glycogen content (e) was determined at the end of the experiment. Data are given as means±SEM (some SEMs are hidden by symbols); *p<0.05; **p<0.01; ***p<0.001 vs basal conditions. † p<0.05; † † p<0.01; † † † p<0.001 vs absence of progesterone branes as described previously [22] . They were then exposed overnight at 4°C to antisera 7790 or T2 for progesterone receptor membrane component 1 protein (28 kDa), which were generously provided by M. Lösel (University of Heidelberg, Germany). Then, they were exposed to the secondary antibody (peroxidase-labelled anti-rabbit IgG from Amersham) for 60 min at room temperature. The bands were visualised using Super Signal System from Pierce (Rockford, IL, USA) and Kodak XAR5-Omat films (Kodak, Rochester, NY, USA).
Statistics
According to the exploratory character of the study, statistics were used in a descriptive sense. Results are given as means±SEM, differences were analysed by paired or unpaired two-tailed Student's t tests with p<0.05 considered as significant.
Results
Progesterone action on isolated rat muscle
Dependence on dose and insulin In isolated soleus muscle from male rats, progesterone shifted basal glucose metabolism from the aerobic to the anaerobic pathway, which was reflected by a dose-dependent reduction of basal rates of glucose oxidation, accompanied by increasing rates of lactate release ( Fig. 1 ; ratio of basal glucose oxidation/ lactate production, arbitrary units: control, 1.00±0.07; 1 μmol/l progesterone, 0.81±0.07, p<0.05; 10 μmol/l progesterone, 0.43±0.04, p<0.001; 50 μmol/l progesterone, 0.13± 0.01, p<0.001). This was associated with an increase in glucose transport and a decrease in net glycogen synthesis (i.e. glycogen depletion), which obviously reflected increased carbohydrate requirements to compensate for the much lower yield of ATP from anaerobic than aerobic metabolism.
The same shift from the aerobic towards the anaerobic pathway was observed for insulin-stimulated glucose metabolism (ratio of insulin-stimulated glucose oxidation/lactate production, arbitrary units: control, 1.00±0.07; 1 μmol/l progesterone, 0.72±0.04, p<0.05; 10 μmol/l progesterone, 0.39± 0.03, p < 0.001; 50 μmol/l progesterone, 0.19 ± 0.09, p<0.001), but at variance with what was seen under basal conditions, glucose transport and lactate release decreased markedly between 10 and 50 μmol/l progesterone (Fig. 1) . The pattern of response was basically the same in extensor digitorum longus muscle and in soleus muscle from female rats and, hence, the described actions of progesterone were, at least largely, independent of sex and fibre composition [Electronic Supplementary Material (ESM) Fig. 1 ].
As the observed response suggested impairment of cell respiration, we next measured the effect of progesterone on pyruvate oxidation. A marked decrease of pyruvate oxidation indicated that progesterone inhibited cell respiration downstream of glycolysis, i.e. within the mitochondrion (Fig. 2a) . Additions of 0.3% (w/v) BSA plus 300 μmol/l G lu c o s e o x id a t io n G lu c o s e t r a n s p o r t L a c t a t e r e le a s e G ly c o g e n s y n t h e s is G ly c o g e n c o n t e n t * * *** * Fig. 3 Comparison of concentrations of progesterone and rotenone that cause the same impairment of glucose oxidation. Strips of rat soleus muscle were incubated for 5 h with 10 μmol/l progesterone (data adapted from Fig. 1 ; closed bars) or with 60 nmol/l rotenone (open bars). Insulin-stimulated (25 nmol/l) rates of glucose oxidation, glucose transport, lactate release and net glycogen synthesis were measured during the last hour. Glycogen content was determined at the end of the experiment. Data are given as percentage change vs an intra-individual control as means±SEM; *p<0.05; ***p<0.001 for progesterone vs rotenone palmitate to the incubation medium, which are prerequisites for measuring the rate of palmitate oxidation, very modestly blunted the effect of progesterone on muscle glucose metabolism, presumably due to binding of progesterone to BSA and/or the availability of an alternative fuel substrate (ESM Table 1 ). Under these conditions, palmitate oxidation was also reduced by progesterone (Fig. 2b ), but to a much lesser extent than glucose oxidation (at 50 μmol/l progesterone: palmitate oxidation, −17±6%, vs glucose oxidation, −49±6%; p=0.002). This result excludes a progesteroneinduced increase in lipid utilisation as the cause of reduced glucose oxidation. In line with impaired mitochondrial fuel oxidation, progesterone dose-dependently reduced the ratio of phosphocreatine/ATP, a measure of the cellular energy charge (Fig. 2c) , and the energy-dependent process of protein synthesis was also reduced by a high concentration of progesterone (nmol methionine incorporated g
control, 31±2; 1 μmol/l progesterone, 36±2, NS; 10 μmol/l progesterone 29±3, NS; 50 μmol/l progesterone, 17±1, p<0.001).
In spite of such obvious inhibition of cell respiration, the effect of progesterone differed considerably from that of rotenone, a 'classic' and specific inhibitor of cell respiration. Rotenone at 60 nmol/l caused the same decrease in glucose oxidation as 10 μmol/l progesterone (both −39%; Fig. 3 ), but triggered several-fold larger compensatory increments in glucose transport and lactate release, while glycogen depletion was less pronounced (Fig. 3 ). These differences indicate that progesterone blunted the increase in cellular glucose uptake as usually seen in response to reduced cell respiration, which limited substrate availability for anaerobic glycolysis and increased the demand for glycogen-derived substrate. Taken together, the results thus implicate a dual effect of progesterone-inhibition of cell respiration in parallel with suppression of a compensatory increase in glucose uptake.
Time dependence Progesterone-induced reductions of net glycogen synthesis and glucose oxidation occurred very rapidly, within 30 min, and almost the full amplitude of the response seen after 5 h was reached within the first 1.5 h (Fig. 4a,b) . At variance with what was found after prolonged exposure, lactate release was increased after 30 min of exposure to 50 μmol/l progesterone, apparently because glycogen stores were not yet depleted and provided substrate for anaerobic glycolysis (Fig. 4c,d) .
Progesterone action was rapid not only in occurrence, but also faded immediately after termination of continuous Interaction with inhibitors Since rapid occurrence and fading strongly hint at a non-genomic mode of action, we further examined dependence on genomic vs non-genomic mechanisms using established blockers of transcription (actinomycin D), protein synthesis (cycloheximide) and of the nuclear progesterone receptor, which is responsible for at least most genomic actions of the steroid (RU-486). No inhibitor counteracted the progesterone-induced impairment of muscle glucose metabolism, which excludes a genomic mechanism of action (Fig. 6 ).
Comparison with other steroids Several other steroids were tested under the same experimental conditions as progesterone. At a concentration of 50 μmol/l, all of them affected glucose metabolism in a qualitative manner reminiscent of the effects exerted by progesterone. However, the amplitudes of the effects were less pronounced than with progesterone in the following ranking: progesterone ≫ testosterone ≈ oestradiol > corticosterone ≈ 17-OH-progesterone > cortisol ≈ aldosterone ≈ dexamethasone (Fig. 7) .
Expression of Pgrmc1
Progesterone receptor membrane component 1, a putative cell-surface receptor for progesterone (or a part of it) is believed to mediate non-genomic actions in various cells [23] [24] [25] [26] . Based on evidence for a non-genomic mode of action we determined if this putative receptor is expressed in rat skeletal muscle. In line with a previous study on pigs [27] , Pgrmc1 mRNA was found in liver and spleen, with a 
Actinomycin D Progesterone Cycloheximide RU-486 *** ** *** *** *** *** *** *** ** ** *** *** *** *** *** *** Data are given as a percentage of an intra-individual control and as means± SEM; *p<0.05; **p<0.01; ***p<0.001 vs control (=100%). 17-0H-Progesterone, 17-hydroxyprogesterone more intense signal obtained from liver samples (Fig. 8a) . In addition, we show for the first time that Pgrmc1 mRNA is expressed in rat skeletal muscles of various fibre composition (Fig. 8a) . The corresponding progesterone receptor membrane component 1 protein (28 kDa) was clearly detected by western blotting with both employed antibodies 7790 (Fig. 8b) and T2 (Fig. 8c ).
Discussion
Although a direct effect of progesterone on skeletal muscle could explain many of the metabolic changes associated with late pregnancy, early evidence for the existence of such actions was not pursued [10, 16] . The present study resumed this line of research and analysed the influence of progesterone on substrate fluxes through the various pathways of glucose metabolism. It is shown that progesterone, via a rapid and direct effect on rat skeletal muscle, shifts glucose flux from the aerobic into the anaerobic pathway, which indicates impaired cell respiration. Impairment of cell respiration usually triggers a compensatory increase in glucose transport to cover elevated fuel requirements for anaerobic ATP production [29, 30] , but this response is markedly blunted under progesterone exposure. Such a combination of increased glucose demands with impaired recruitment of additional glucose necessarily results in a distinct shortage of intracellular carbohydrate availability. The consequences of cellular carbohydrate shortage in progesterone-exposed muscle strips include: (1) accelerated depletion of glycogen stores; (2) rates of lactate release that are obviously limited by substrate availability; and (3) a much more distinct reduction in CO 2 production from glucose than from palmitate.
Without doubt, adaptations of glucose homeostasis during late pregnancy rely on the concerted actions of many hormones on many tissues, but our results appear readily compatible with the idea that direct progesterone action on skeletal muscle could make a relevant contribution. In isolated muscle, increased lactate release and reduced pyruvate oxidation were observed after exposure to 1 μmol/l progesterone, a concentration that is reached in plasma of pregnant women and rats [3, 4] . Hence, a surplus of lactate from skeletal muscle could contribute to elevated plasma concentrations as well as to increases in hepatic lactate uptake and in gluconeogenesis from lactate of pregnant rats [31, 32] . Furthermore, the described effects on glucose transport into muscle could obviously contribute to the gestational reduction in glucose disposal [1, 2] . In summary, the picture thus fits with the proposed biological meaning of late gestational adaptations, which is to redirect carbohydrate flux from storage in maternal tissues towards availability for fetal development.
Regarding the mechanism of progesterone action, our findings leave not doubt that the described actions of progesterone are non-genomic. This is indicated by immediate occurrence and fading of the response as well as by its persistence under exposure to specific inhibitors of transcription, protein synthesis or of the 'classic' intracellular progesterone receptor. Although a relatively low concentration of 1 μmol/l progesterone was effective, we can not finally exclude an 'unspecific', i.e. receptor-independent, mechanism of action. However, findings reported by others suggest that progesterone can trigger non-genomic effects via proteins that are located in the plasmalemma and function as receptors [13, 25, 33, 34] . In line with putative signal transduction via a cell-surface receptor, a relatively low concentration of BSA-coupled progesterone, which is [28] . M., muscle; EDL, extensor digitorum longus; Epitr., epitrochlearis; Gastr., gastrocnemius unable to enter the cell, induced a trend to reduced net glycogen synthesis in our experimental setting (p=0.051; ESM Fig. 2) .
So far, the search for cell-surface receptors for progesterone has suggested two candidate proteins, one of which is not expressed in human skeletal muscle and is therefore unlikely to mediate the effects described here [33] . The second candidate, referred to as progesterone receptor membrane component 1, is believed to be implicated in various rapid non-genomic effects of progesterone including the modulation of apoptosis in granulosa and luteal cells [26] and the induction of Ca 2+ fluxes and the acrosome reaction in sperm [24, 25] . We show for the first time that this putative receptor is expressed in rat skeletal muscle and is therefore available for signal transduction. Furthermore, the hierarchy of several steroids as mimickers of progesterone action in isolated muscle has noticeable parallels with their presumptive binding affinities to progesterone receptor membrane component 1 (progesterone ≫ testosterone ≈ oestradiol > corticosterone > cortisol ≥ aldosterone ≈ dexamethasone) [24, 28] . An exception in this regard is oestradiol, which is relatively more effective in muscle, but distinct non-genomic actions ascribed to oestradiol and evidence for oestrogen receptors located directly on mitochondria raise the possibility that this particular steroid affects muscle metabolism via its own specific pathway [13, 35] . Although final conclusions can not be drawn at this stage, our results are at least compatible with the idea that progesterone receptor membrane component 1 could be the mediator of the observed effects.
In summary, we show that progesterone acts directly on rat skeletal muscle via a rapid non-genomic mechanism that impairs cell respiration and at the same time suppresses a compensatory increase in glucose transport. The results are compatible with a possible contribution of this mechanism to the characteristic changes in carbohydrate metabolism seen during late pregnancy.
